Carasent Group Secures Major Contract to Integrate Medrave M4 with VGR’s EHR system

Västra Götalands Regionen (VGR) has chosen Medrave AB, a subsidiary of Carasent Group, to integrate the Medrave M4 software with their newly adopted Electronic Health Record (EHR) system, Millennium.
  • about 5 minutes to read

This partnership marks a major step forward in operational monitoring and automatic reporting for healthcare quality registries. Under the terms of the agreement, which extends for six years, Medrave AB will provide its advanced Medrave M4 solution, replacing parts of the previous system used by VGR.

This change comes as VGR transitions to a new EHR system, necessitating a fresh tender which Medrave successfully won. The contract guarantees Medrave AB an annual recurring revenue (ARR) of NOK 11 million after the implementation process, with an additional NOK 2 million expected from consultancy services in the first year. VGR will also maintain its current subscription with Medrave for their old EHR system. As long as they do so, the costs for this older service, amounting to NOK 4-5 million, will be deducted from the new contract’s value.

Implementation of the new system is slated for completion by November 2024, after which the new revenue will commence. Daniel Öhman, CEO of Carasent, expressed his enthusiasm about the continued partnership with VGR, highlighting Medrave’s unique capabilities in enhancing primary care quality through its precise follow-up and automated reporting features.

– In a short period, we have now signed the two largest customer contracts in Carasent’s history. Signed but not implemented ARR is now approximately NOK 14 million (NOK 6 million from the new VGR agreement) up from NOK 2 million Q1 2023. Revenue growth is the key to driving our profit margins given that we aim to keep the cost base flat, and this new ARR will contribute significantly, as our gross margins are over 80%.

Medrave Software AB, established in 1996 and later acquired by Carasent Group in 2021, remains at the forefront of healthcare business intelligence solutions in Sweden. It is extensively utilized, serving over 90% of primary healthcare centres and 1,000 outpatient clinics across the country.

For further inquiries, contact Daniel Öhman, CEO at +46 70-855 37 07, or Svein Martin Bjørnstad, CFO at +47 979 69 493.

More news

Carasent is delighted to welcome Stefan Jernberg as the group's new Chief Compliance Officer. Stefan brings a wealth of experience and expertise in compliance, having a strong background in software development, MedTech, and extensive knowledge of regulatory frameworks.
Read more
HPI, Health Profile Institute, has contributed to a new study conducted at the University of Gothenburg. The study shows that individuals who maintain or increase their fitness have a reduced risk of future hospital admissions, especially if they have previously been hospitalized.
Read more
Volvat Medisinske Senter AS and Metodika AB have entered into an agreement to implement the EHR system Metodika EPM at Volvat’s hospitals and clinics in Norway. The annual revenue from the contract is estimated to 7-9 MNOK, where the majority is recurring revenue (“ARR”)
Read more
Carasent ASA is set to embark on an exciting new phase as it updates its long-term financial targets for revenue growth and profitability. The detailed presentation will take place today at the Capital Markets Day (CMD).
Read more
Carasent ASA has acquired the Swedish company HPI Health Profile Institute AB, a leading software solutions provider for occupational healthcare in Sweden.
Read more
The board of directors of Carasent ASA has today appointed Daniel Öhman as the Company’s new Chief Executive Officer (CEO). He will succeed Dennis Höjer, who has been CEO since December 2020. Öhman will start no later than 2 January 2023.
Read more
BUSINESS ADDRESS
CONTACT US
Linkedin-in

2024 Carasent. All rights reserved by Carasent ASA.